Adductor Canal Block and IPACK Block vs Adductor Canal Block and the Gastrosoleus Interfascial Block After Total Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorFayoum University Hospital

About this trial

Evaluate analgesic efficacy of adductor canal block with IPACK versus that of adductor canal block with gastrosoleus interfascial plane block in total knee arthroplasty surgeries.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients of ASA class I to III of both sexes

undergoing unilateral total knee arthroplasty

40-80 years old

Disqualifiers

Patient refusal

History of coagulopathies

Severe renal insufficiency

Preexisting lower limb neurological abnormality

Trial design

Design model

Parallel

Treatments tested in this trial

  • Adductor Canal Block (ACB) + gastrosoleus interfascial plane block

    Procedure/Surgery

    Adductor canal block will be given. In supine position, the leg will be externally rotated and the probe will be positioned at the midpoint of the thigh on its medial aspect. The adductor canal (AC) will be located anterolaterally to the superficial femoral artery deep to the sartorius muscle. The needle (size) will be advanced and a particular "pop" will be felt when the tip pierced the vastoadductor membrane, which is the roof of the adductor canal. A single dose of (20 ml of 0.25% bupivacaine) will be injected. The patients will receive gastrosoleus interfascial plane block. Using a linear probe the transducer will be placed along the medial border of the leg in long axis, 7 cm-8 cm below the popliteal crease. After identification of muscle bellies of the medial gastrocnemius head, the soleus and the trilaminar fascial plane between these muscles, 20 ml of bupivacaine 0.25% will be injected at this plane by piercing the fascia (loss of resistance).

  • Adductor Canal Block (ACB) + iPACK Block

    Procedure/Surgery

    Adductor canal block will be given. In supine position, the leg will be externally rotated and the probe will be positioned at the midpoint of the thigh on its medial aspect. The adductor canal (AC) will be located anterolaterally to the superficial femoral artery deep to the sartorius muscle. The needle (size) will be advanced and a particular "pop" will be felt when the tip pierced the vastoadductor membrane, which is the roof of the adductor canal. A single dose of (20 ml of 0.25% bupivacaine) will be injected. The patients will recieve IPACK with the patient placed in a supine position and knee placed in position of 90° flexion. By placing a low-frequency ultrasound probe in the popliteal crease the spinal needle will be advanced from medial aspect of the knee going from anteromedial to posterolateral between the popliteal artery and the femur. The tip of the needle will be placed 1-2 cm beyond the lateral edge of the artery, and 20 ml of 0.25% bupivacaine will be injected.

Treatment groups

86 Participants
are divided into 2 treatment groups
Group A: ACB/GIP groupExperimental treatment 1 intervention
Group B: ACB/IPACK groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative pain using visual analogue score VAS score

• Postoperative pain using vas score where 0 is worst pain, 10 is no pain

Time frame
change in VAS score 30 min after arrival to PACU change in VAS score 4 hours after arrival to PACU change in VAS score 8 hours after arrival to PACU change in VAS score 12 hours after arrival to PACU change in VAS score 24 hours after arrival to PACU

Secondary outcomes

1

Time to first morphine analgesic dose and total rescue doses of morphine.

Time to first morphine analgesic dose in hours.

Time frame
time needed for patient to use morphine in hours after end of surgery
2

cumulative doses of morphine

cumulative doses of morphine in mg

Time frame
cumulative doses of morphine in mg in the first 24 hours after operation
3

Range of motion by assessing degree of knee extension 24 hours after surgery.

Range of motion by assessing degree of knee extension 24 hours after surgery.

Time frame
Assessing degree of knee extension 24 hours after surgery.
4

Time of first postoperative ambulation and how many feets the patient will be able to walk.

Time of first postoperative ambulation and how many feets the patient will be able to walk.

Time frame
Time of first postoperative ambulation and how many feets the patient will be able to walk in the 24 hours after operation

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: